DRKS00005711招募中不适用
on-interventional study on treAtment of chemotherapy-inDuced neutropenia with LIpefilgRastim (XM22) - NADIR
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- TEVA GmbH
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Patients receiving antineoplastic therapy who will be treated for the first time with lipefilgrastim (XM22) for prevention or therapy of chemotherapy-induced neutropenia in the current treatment cycle
- •2. Adult male and female patients (at least 18 years with no upper age limit)
- •3. Written informed consent to collecting and pseudonymized data transmission.
排除标准
- •1. Prior treatment with lipefilgrastim (XM22)
- •2. Missing patient’s informed consent
- •3. Treatment with another G-CSF formulation during the current line of chemotherapy
- •4. Pregnant or breast-feeding women
- •5. Planned myelosuppressive or myeloablative therapy with stem cell support
- •6. Existing or newly diagnosed myelodysplastic syndrome (MDS), chronic myeloid (CML) or acute myeloid leukemia (AML)
- •7. Known severe chronic neutropenia, congenital neutropenia or idiopathic or cycle neutropenia
- •8. Known HIV positivity
研究者
相似试验
进行中（未招募）
1 期
Study evaluating the effects of chemotherapy on incurable cancer of the esophagus or stomachEsophagogastric adenocarcinomaMedDRA version: 18.1Level: PTClassification code 10062878Term: Gastrooesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-000127-24-DKRigshospitalet, Department of Oncology98
已完成
不适用
Evaluation of effect of chemotherapy for depiction of metastatic liver tumor on gadoxetate disodium enhanced MRIJPRN-UMIN000005401Hiroshima University20
已完成
不适用
A prospective study of the effect of chemotherapy on metabolic and cardiovascular function in women with early stage breast cancerEarly stage breast cancerCancer - BreastACTRN12614001055695A/Prof Bogda Koczwara29
进行中（未招募）
1 期
A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as pre-operative treatment for locally recurrent rectal cancer (GRECCAR – PRODIGE – FRENCH) - GRECCAR 15Recurrent rectal cancer after local excision, Rectal cancerMedDRA version: 20.0Level: PTClassification code: 10038038Term: Rectal cancer Class: 100000004864CTIS2024-514705-62-00Centre Hospitalier Universitaire De Bordeaux186
招募中
3 期
A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as pre-operative treatment for locally recurrent rectal cancer (GRECCAR – PRODIGE – FRENCH) - GRECCAR 152024-514705-62-00Centre Hospitalier Universitaire De Bordeaux186